ScholarIQanswers from OpenAlex & ORCID
Daphne S. Bakker
ResearcherPublications, citations & collaboration network
Daphne S. Bakker is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Daphne S. Bakker have?
ScholarIQindexed works
Daphne S. Bakker has 58 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Daphne S. Bakker have?
ScholarIQcitation count
Daphne S. Bakker has 1,538 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Daphne S. Bakker?
ScholarIQh-index
Daphne S. Bakker has an h-index of 22 in OpenAlex.
What is the i10-index of Daphne S. Bakker?
ScholarIQi10-index
Daphne S. Bakker has an i10-index of 32 in OpenAlex.
What is the ORCID of Daphne S. Bakker?
ScholarIQorcid
The ORCID for Daphne S. Bakker is on the source record.
What is the OpenAlex record for Daphne S. Bakker?
ScholarIQopenalex
The OpenAlex for Daphne S. Bakker is on the source record.
What are the most-cited papers on Daphne S. Bakker?
ScholarIQmost cited works
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
Daphne S. Bakker, Lieneke F.M. Ariëns, C. van Luijk, Jorien van der Schaft, Judith L. Thijs, Marie L. A. Schuttelaar, Femke van Wijk, Edward F. Knol, Deepak M.W. Balak, Marijke R. van Dijk, Marjolein de Bruin‐Weller
Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Lieneke F.M. Ariëns, Jorien van der Schaft, Daphne S. Bakker, Deepak M.W. Balak, Margreet L. E. Romeijn, T. Kouwenhoven, Marijke Kamsteeg, Barbara Giovannone, Julia Drylewicz, Cynthia C. A. van Amerongen, Evelien M. Delemarre, Edward F. Knol, Femke van Wijk, Stefan Nierkens, Judith L. Thijs, Marie L. A. Schuttelaar, Marjolein de Bruin‐Weller
Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers
Daphne S. Bakker, Stefan Nierkens, Edward F. Knol, Barbara Giovannone, Eveline M. Delemarre, Jorien van der Schaft, Femke van Wijk, Marjolein de Bruin‐Weller, Julia Drylewicz, Judith L. Thijs
Biomarkers in atopic dermatitis
Daphne S. Bakker, Marjolein de Bruin‐Weller, Julia Drylewicz, Femke van Wijk, Judith L. Thijs
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry
Lieneke F.M. Ariëns, Jorien van der Schaft, Lotte S. Spekhorst, Daphne S. Bakker, Geertruida L. E. Romeijn, T. Kouwenhoven, Marijke Kamsteeg, Angelique N. Voorberg, Albert J. Oosting, Ilona de Ridder, Annemieke Sloeserwij, Inge Haeck, Judith L. Thijs, Marie L. A. Schuttelaar, Marjolein de Bruin‐Weller